Schizophrenia

Schizophrenia is a severe, chronic mental disorder characterized by hallucinations, delusions, disorganized thinking, and impaired ability to function — profoundly affecting how a person perceives reality and engages with the world. The prevalence of schizophrenia among U.S. adults is estimated at approximately 3.7 million people, or 1.2% of adults between the ages of 18 and 65, and it ranks as the third leading cause of disability worldwide. Onset typically occurs in late adolescence to early adulthood, with males generally diagnosed 3 to 5 years earlier than females. Racial disparities in diagnosis are pronounced — Black individuals in the U.S. are approximately 2.4 to 3 times more likely to receive a schizophrenia diagnosis than White individuals, a pattern increasingly attributed to structural inequities rather than differences in underlying prevalence. The human and economic toll is enormous: the estimated economic burden of schizophrenia in the U.S. was $343.2 billion in 2019, more than doubling in just six years. People with schizophrenia lose an estimated average of 28.5 years of potential life, largely due to preventable physical illness and elevated suicide risk. Antipsychotic medications and coordinated specialty care programs can significantly improve outcomes, but access to consistent, high-quality care remains a major challenge.